Skip to main content

Table 3 Short term (in-hospital or 30-days) outcomes of TTVI devices

From: Advances in transcatheter mitral and tricuspid therapies

  Trial/study Technical successa Mortality TR volume reduction (mL)
TriAlign SCOUT I [67] NCT02574650 SCOUT II is enrolling 12/15 0 −2.7 ± 39.5
TriCinch Giannini and Colombo [66] PREVENT ongoing NCT03632967 20/24
Cardioband TRI-REPAIR [68] TriBAND ongoing NCT03779490 28/30 2/30 −35.6 ± 35.3
MitraClip and TriClip Nickenig et al. [69] TRILUMINATE NCT03227757 [70] 6/64
10/85
3/64
0
−26.4 ± 7.8
− 18.6 ± 21.2
FORMA Perlman and Dvir [71,72,73] SPACER enrolling NCT02787408 2/47
  1. a no standardized definition for “technical success” for TTVI